Linda Banta, MD
Dermatology · San Antonio, TXNPI 1144221359
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $28,772 of the $37,665 with a category attached, or 76.4%. AbbVie accounts for 87.1% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2021 at $18,773 and has fallen 98.5% since, to $275 in 2025. Among dermatology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 365 payments — averaging $103.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$33K
- Johnson & Johnson$951
- Lilly USA, LLC$537
- Pfizer$493
- Janssen Scientific Affairs, LLC$375
- Almirall LLC$308
- plus $2K from 25 others
What the payments were for
- Consulting fees$1,0003%
- Speaking & faculty fees$28,77276%
- Travel & lodging$100%
- Food & beverage$7,68120%
- Education$2021%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 173 | $32,793 |
| Johnson & Johnson | 37 | $951 |
| Lilly USA, LLC | 23 | $537 |
| Pfizer | 14 | $493 |
| Janssen Scientific Affairs, LLC | 3 | $375 |
| Almirall LLC | 18 | $308 |
| Sun Pharmaceutical Industries Inc. | 14 | $275 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $257 |
| Regeneron Healthcare Solutions, Inc. | 4 | $254 |
| Incyte Corporation | 11 | $244 |
| Organon | 1 | $136 |
| Amgen | 5 | $125 |
| Galderma Laboratories, L.p. | 7 | $116 |
| E.r. Squibb & Sons, L.L.C. | 5 | $106 |
| Journey Medical Corporation | 5 | $100 |
| Genentech USA, Inc. | 5 | $89 |
| Novartis | 4 | $87 |
| UCB, Inc. | 3 | $67 |
| Biofrontera Inc. | 4 | $62 |
| Sanofi | 2 | $41 |
| Merck | 3 | $37 |
| Arcutis Biotherapeutics, Inc. | 2 | $37 |
| Nabriva Therapeutics, PLC | 2 | $35 |
| Revance Therapeutics, Inc. | 2 | $31 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| EPI Health, LLC | 4 | $18 |
| Mayne Pharma Commercial LLC | 1 | $17 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| LEO Pharma Inc. | 1 | $15 |
| Encore Dermatology Inc. | 1 | $13 |
| Sebela Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$37,665 in reported general payments places this provider in the 90th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in San Antonio
- William CragunSan Antonio$2.2M
- Emily BeckerSan Antonio$1.2M
- Lindsey FinkleaSan Antonio$435K
- John BrowningSan Antonio$351K
- Vivian BucaySan Antonio$241K
- Annabelle GarciaSan Antonio$215K
- Edward LainAustin$2.5M
- Alpesh DesaiHouston$1.6M
- Craig TellerBellaire$1.3M
- Jennifer CatherDallas$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.